Predictive Model and Risk Score for In-Hospital Mortality in Patients with All-Cause Cardiogenic Shock

Federico García-Rodeja Arias1,2, Marta Alonso-Fernandez-Gatta3, Marta Pérez Dominguez1,2

  • 1Department of Department, Complejo Hospitalario Universitario de Santiago de Compostela.

International Heart Journal
|November 13, 2022
PubMed

Insights

A new Santiago Shock Score (S3) effectively predicts in-hospital mortality in cardiogenic shock (CS) patients. This score aids in stratifying patient risk, guiding clinical decisions for better outcomes.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Clinical Risk Stratification

Background:

  • Cardiogenic shock (CS) presents significant challenges with high morbidity and mortality rates.
  • Effective risk stratification is crucial for managing CS patients and optimizing treatment strategies.

Purpose of the Study:

  • To develop and validate a novel risk score, the Santiago Shock Score (S3), for predicting in-hospital mortality in patients with cardiogenic shock.
  • To compare the predictive accuracy of the S3 score against the existing CardShock score.

Main Methods:

  • Retrospective analysis of 135 patients admitted with CS between 2011 and 2020.
  • Development of the S3 score using clinical, analytical, and echocardiographic variables at admission.
  • Evaluation of the S3 score's predictive performance using the area under the receiver operating characteristic curve (AUC).

Main Results:

  • The overall in-hospital mortality rate was 41.5%, with acute coronary syndrome (ACS) as the primary cause in 60.7% of cases.
  • The S3 score demonstrated good accuracy in predicting in-hospital mortality (AUC 0.85), outperforming the CardShock score (AUC 0.74).
  • Three risk categories (low, intermediate, high) were defined by the S3 score, showing distinct mortality rates (12.9%, 49.1%, 87.5%, respectively).

Conclusions:

  • The S3 score exhibits excellent predictive power for in-hospital mortality in non-profound CS patients.
  • The S3 score can assist in the initial risk stratification of CS patients.
  • Implementation of the S3 score may guide treatment decisions and improve clinical management of CS.

Related Concept Videos